Collegium Pharmaceutical Inc (COLL) is near the top in its industry group according to InvestorsObserver. COLL gets an overall rating of 67. That means it scores higher than 67 percent of stocks. Collegium Pharmaceutical Inc gets a 92 rank in the Drug Manufacturers - Specialty & Generic industry. Drug Manufacturers - Specialty & Generic is number 107 out of 148 industries.
COLL has an Overall Score of 67. Find out what this means to you and get the rest of the rankings on COLL!
Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.
What's Happening With Collegium Pharmaceutical Inc Stock Today?
Collegium Pharmaceutical Inc (COLL) stock has gained 3.64% while the S&P 500 has fallen 0% as of 12:18 PM on Monday, Nov 13. COLL is up $0.89 from the previous closing price of $24.48 on volume of 263,196 shares. Over the past year the S&P 500 has risen 11.57% while COLL is up 27.23%. COLL earned $0.07 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 352.36.
Click Here to get the full Stock Report for Collegium Pharmaceutical Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
